Anaptysbio (ANAB) Preferred Dividend Payments (2016)
Anaptysbio's (ANAB) quarterly Preferred Dividend Payments came in at $2.1 million in Q2 2016.
Analysis
Anaptysbio (ANAB) Preferred Dividend Payments (2016) Analysis & Trends
Anaptysbio (ANAB) has 1 years of Preferred Dividend Payments data on file, last reported at $2.1 million in Q2 2016.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.1 million in Q2 2016, while the trailing twelve-month figure through Sep 2017 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at -$82000.0, down 46.43% from the prior year.
- Preferred Dividend Payments was little changed at $2.1 million in Q2 2016.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.1 million in Q2 2016 to a low of $2.1 million in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Anaptysbio | 1.62 Bn | 1.33 Bn | - | - |